Isoliquiritigenin Inhibits Gastric Cancer Stemness, Modulates Tumor Microenvironment, and Suppresses Tumor Growth
Chien-Hsing Lee1,2,3,4, Hsin-Yi Tsai5,6, Chun-Lin Chen7
1Department of Pharmacology, School of Post-Baccalaureate Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
Abstract:
Chemotherapy is the treatment of choice for gastric cancer; however, the currently available therapeutic drugs for treatment have limited efficacy. Cancer stemness and the tumor microenvironment may play crucial roles in tumor growth and chemoresistance. Glucose-regulated protein 78 (GRP78) is an endoplasmic reticulum chaperone facilitating protein folding and cell homeostasis during stress and may participate in chemoresistance. Isoliquiritigenin (ISL) is a bioactive flavonoid found in licorice. In this study, we demonstrated the role of GRP78 in gastric cancer stemness and evaluated GRP78-mediated stemness inhibition, tumor microenvironment regulation, and chemosensitivity promotion by ISL. ISL not only suppressed GRP78-mediated gastric cancer stem cell-like characteristics, stemness-related protein expression, and cancer-associated fibroblast activation but also gastric tumor growth in xenograft animal studies. The findings indicated that ISL is a promising candidate for clinical use in combination chemotherapy.
Insights
Isoliquiritigenin (ISL) combats gastric cancer by inhibiting cancer stemness and regulating the tumor microenvironment. This flavonoid enhances chemotherapy efficacy, offering a promising approach for clinical treatment.
Area of Science:
- Oncology
- Cancer Biology
- Pharmacology
Background:
- Chemotherapy for gastric cancer has limited efficacy, potentially due to cancer stemness and the tumor microenvironment.
- Glucose-regulated protein 78 (GRP78), an endoplasmic reticulum chaperone, is implicated in chemoresistance.
- Isoliquiritigenin (ISL), a flavonoid from licorice, has bioactive properties.
Purpose of the Study:
- To investigate the role of GRP78 in gastric cancer stemness.
- To evaluate the effects of ISL on GRP78-mediated stemness, tumor microenvironment, and chemosensitivity.
- To assess ISL's potential as a therapeutic agent for gastric cancer.
Main Methods:
- Evaluation of GRP78's role in gastric cancer stemness.
- Assessment of ISL's impact on GRP78-mediated stemness inhibition, tumor microenvironment regulation, and chemosensitivity.
- Xenograft animal studies to evaluate gastric tumor growth inhibition by ISL.
Main Results:
- ISL suppressed GRP78-mediated gastric cancer stem cell-like characteristics and stemness-related protein expression.
- ISL inhibited cancer-associated fibroblast activation and reduced gastric tumor growth in vivo.
- ISL demonstrated potential in regulating the tumor microenvironment and enhancing chemosensitivity.
Conclusions:
- ISL effectively targets GRP78-mediated cancer stemness and modulates the tumor microenvironment in gastric cancer.
- ISL exhibits anti-tumor activity and enhances chemosensitivity, suggesting a role in overcoming chemoresistance.
- ISL is a promising candidate for combination chemotherapy in clinical settings for gastric cancer treatment.
Related Concept Videos
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...


